The Times of India
Dipan Mehta of Elixir Equities suggests the pharma sector is facing headwinds from potential US tariffs, impacting margins amid strong competition. He recommends focusing on the CDMO space, highlighting Divi’s Laboratories as a strong player. Other promising …
Read More
Market to stay in sideways zone without earnings boost; CDMO’s the best way to play pharma: Dipan Mehta
ET Now
08:29
Dipan Mehta of Elixir Equities suggests the pharma sector is facing headwinds from potential US tariffs, impacting margins amid strong competition. He recommends focusing on the CDMO space, highlighting Divi’s Laboratories as a strong player. Other promising …
